Exact Sciences (EXAS) - יחס מהיר

Geopolitical instability threatens the supply of reagents for Exact Sciences (EXAS) DNA tests and limits the expansion of its technologies. The current ratio indicator, with a metric value of 2.26, helps assess the balance of cash reserves. Profit growth depends on the screening coverage of Cologuard and the control of marketing expenses. The stability of the R&D department and the recruitment of bioinformaticians eliminate the risk of losing key competencies.

The quick ratio assesses a company's ability to instantaneously settle short-term obligations without liquidating inventory. By analyzing changes in quick liquidity, an investor can see the net balance of cash and accounts receivable relative to debt. A high ratio confirms financial stability, eliminating the risk of inventory stockpiling. For Exact Sciences (EXAS), this is critical: reliance on a single test makes the company vulnerable to the emergence of cheaper alternatives or the refusal of insurance companies to provide payouts.